Hyo-Cheol Kim - Search Results

Year	Number of Results
2002	3
2003	6
2004	9
2005	4
2006	4
2007	8
2008	9
2009	14
2010	13
2011	16
2012	13
2013	14
2014	24
2015	20
2016	13
2017	16
2018	13
2019	8
2020	15
2021	18
2022	18
2023	19
2024	4

1

Recent progress in liquid embolic agents.

Ko G, Choi JW, Lee N, Kim D, Hyeon T, Kim HC. Ko G, et al. Among authors: kim hc. Biomaterials. 2022 Aug;287:121634. doi: 10.1016/j.biomaterials.2022.121634. Epub 2022 Jun 13. Biomaterials. 2022. PMID: 35716628 Review.

2

Radioembolization for the treatment of hepatocellular carcinoma.

Kim HC. Kim HC. Clin Mol Hepatol. 2017 Jun;23(2):109-114. doi: 10.3350/cmh.2017.0004. Epub 2017 May 10. Clin Mol Hepatol. 2017. PMID: 28494530 Free PMC article. Review.

3

Role of Yttrium-90 Radioembolization for Colorectal Hepatic Metastasis.

Kim HC. Kim HC. Korean J Radiol. 2022 Feb;23(2):156-158. doi: 10.3348/kjr.2021.0867. Korean J Radiol. 2022. PMID: 35083891 Free PMC article. No abstract available.

4

A Phase I/IIa Trial of Yttrium-90 Radioembolization in Combination with Durvalumab for Locally Advanced Unresectable Hepatocellular Carcinoma.

Lee YB, Nam JY, Cho EJ, Lee JH, Yu SJ, Kim HC, Paeng JC, Yoon JH, Kim YJ. Lee YB, et al. Among authors: kim hc. Clin Cancer Res. 2023 Sep 15;29(18):3650-3658. doi: 10.1158/1078-0432.CCR-23-0581. Clin Cancer Res. 2023. PMID: 37459133 Clinical Trial.

5

Radioembolization for hepatocellular carcinoma: what clinicians need to know.

Choi JW, Kim HC. Choi JW, et al. Among authors: kim hc. J Liver Cancer. 2022 Mar;22(1):4-13. doi: 10.17998/jlc.2022.01.16. Epub 2022 Feb 23. J Liver Cancer. 2022. PMID: 37383534 Free PMC article. Review.

6

Early-Stage HCC Percutaneous Locoregional Management: East versus West Perspectives.

Iezzi R, Posa A, Contegiacomo A, Lee IJ, Bale R, Tanzilli A, Tenore L, Giuliante F, Gasbarrini A, Goldberg SN, Jakobs T, Pompili M, Bargellini I, Sala E, Kim HC. Iezzi R, et al. Among authors: kim hc. Cancers (Basel). 2023 Aug 6;15(15):3988. doi: 10.3390/cancers15153988. Cancers (Basel). 2023. PMID: 37568804 Free PMC article. Review.

7

Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis.

Hur MH, Cho Y, Kim DY, Lee JS, Kim GM, Kim HC, Sinn DH, Hyun D, Lee HA, Seo YS, Lee IJ, Park JW, Kim YJ. Hur MH, et al. Among authors: kim hc. Clin Mol Hepatol. 2023 Jul;29(3):763-778. doi: 10.3350/cmh.2023.0076. Epub 2023 May 30. Clin Mol Hepatol. 2023. PMID: 37254488 Free PMC article.

8

Imaging Evaluation Following ⁹⁰Y Radioembolization of Liver Tumors: What Radiologists Should Know.

Joo I, Kim HC, Kim GM, Paeng JC. Joo I, et al. Among authors: kim hc. Korean J Radiol. 2018 Mar-Apr;19(2):209-222. doi: 10.3348/kjr.2018.19.2.209. Epub 2018 Feb 22. Korean J Radiol. 2018. PMID: 29520178 Free PMC article. Review.

9

Chemoembolization combined with radiofrequency ablation is the best option for the local treatment of early hepatocellular carcinoma?

Kim HC. Kim HC. Clin Mol Hepatol. 2023 Oct;29(4):984-986. doi: 10.3350/cmh.2023.0275. Epub 2023 Aug 14. Clin Mol Hepatol. 2023. PMID: 37583053 Free PMC article. No abstract available.

10

Selective Chemoembolization of Caudate Lobe Hepatocellular Carcinoma: Anatomy and Procedural Techniques.

Kim HC, Miyayama S, Chung JW. Kim HC, et al. Radiographics. 2019 Jan-Feb;39(1):289-302. doi: 10.1148/rg.2019180110. Radiographics. 2019. PMID: 30620696 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

237 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

237 results

Results by year